↓ Skip to main content

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues

Overview of attention for article published in EJNMMI Research, June 2012
Altmetric Badge

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
22 Mendeley